
Cambridge Nucleomics awarded Trinity Bradfield Angel Prize 2025
Cambridge Nucleomics is proud to be awarded the 2025 Trinity Bradfield Angel Prize jointly with BioTryp Therapeutics in recognition of achievements over the past 12 months. The prize was evaluated and awarded by a distinguished panel of scientific experts, industry leaders and VCs led by…
Continue reading...
